About Valencelabs
Valencelabs is a Healthcare company based in India. It provides custom synthesis, API manufacturing, and CDMO services for pharmaceuticals. It operates on a B2B model. The company has 77 employees. Its website valencelabs.co draws about 14 thousand monthly visits. Its Indian entity Valence Labs Private Limited reported revenue of ₹11.60 Cr. Valencelabs offers products and services including APIs and Intermediates and CMO and CDMO Services. Its focus areas include Pharmaceutical Tech, API Manufacturing, Custom Synthesis and Contract Services.
Company details
Valence Labs is a research-driven company specializing in pharmaceutical innovation, focusing on chemical and API production. It offers comprehensive custom synthesis services, ensuring smooth transitions from development to commercial manufacturing. The company operates a GMP-compliant facility in Punjab, India, partnering with clients for APIs, intermediates, and contract manufacturing. It emphasizes cost-effective production and employee development while maintaining integrity and quality standards.
- Headquarters India
- Employees 77
- SectorsHealthcare
- Email••••••••
- Website valencelabs.co
- Social LinkedIn
- Legal Name Valence Labs Pvt Ltd
- Date of Incorporation 05 Aug, 2021
- Jurisdiction Mohali, Punjab, India
- Annual Revenue₹11.60 Cr
FY 2025 · +1217% YoY
- Net Loss-₹23.93 Cr
FY 2025 · -206% margin
- EBITDA-₹12.71 Cr
FY 2025 · -110% margin
- Employee Count77
Associated legal entities of Valencelabs
Valencelabs operates through Valence Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Valence Labs Private Limited CIN U24290PB2021PTC053985 | Active | 05 Aug 2021 | Mohali, Punjab | ₹11.6 Cr | 77 | 3 | View details |
Products & Services of Valencelabs
Valencelabs offers a comprehensive portfolio of products and services, including APIs and Intermediates and CMO and CDMO Services.
Products for API manufacturing and pharmaceutical development processes.
Services for custom synthesis and transition to commercial production.
Board of directors of Valence Labs Private Limited (Valencelabs)
Valence Labs Private Limited is the primary company behind Valencelabs. The board of Valence Labs Private Limited currently have 3 directors; the longest-serving is Munish Goyal, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Munish Goyal DIN 00338144 | Director | 05 Aug 2021 | 5 yrs 2 mo | Valence Labs Private Limited |
| Minu Goyal DIN 00371323 | Director | 05 Aug 2021 | 5 yrs 2 mo | Valence Labs Private Limited |
| Harsh Dev Goyal DIN 08220551 | Director | 05 Aug 2021 | 5 yrs 2 mo | Valence Labs Private Limited |
People of Valencelabs
5 people are tracked at Valencelabs (3 in leadership, 2 in team); the tracked headcount is 77.
| Name | Role | Group |
|---|---|---|
Ajay Sharma | Director - Technical | Leadership |
| Managing Director | Leadership | |
| Director | Leadership | |
Gurpreet Singh | Engineering Manager | Team |
Abhishek Mahajan | Manager - EHS | Team |
Complete people profiles for Valencelabs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Valencelabs
Figures of Valence Labs Private Limited, the primary company behind Valencelabs, for FY 2025. Revenue was ₹11.60 Cr (+1217% year on year). Net loss was -₹23.93 Cr (-206% margin). EBITDA was -₹12.71 Cr (-110% margin). Revenue has grown at a compounded annual rate of +275% over three years.
- ₹11.60 CrRevenue · FY 2025 · +1217% YoY
- -₹23.93 CrNet loss · -206% margin
- -₹12.71 CrEBITDA · -110% margin
- ₹6.50 CrPaid-up capital
- 77Employees (provident fund records)
- +275%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Valence Labs Private Limited are on its company page.
Detailed financial statements for Valencelabs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Valencelabs
The website of Valencelabs (valencelabs.co) receives about 14.1K visits a month.
- Monthly visits14.1K
▲ 6.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Valencelabs
Valencelabs is headquartered in India.
Valencelabs has 77 employees.
The primary company behind Valencelabs, Valence Labs Private Limited, reported revenue of ₹11.60 Cr for FY 2025, up 1217% year on year.
Valence Labs is a research-driven company specializing in pharmaceutical innovation, focusing on chemical and API production. It offers comprehensive custom synthesis services, ensuring smooth transitions from development to commercial manufacturing. The company operates a GMP-compliant facility in Punjab, India, partnering with clients for APIs, intermediates, and contract manufacturing. It emphasizes cost-effective production and employee development while maintaining integrity and quality standards.
Valencelabs offers APIs and Intermediates and CMO and CDMO Services.
Valencelabs operates through Valence Labs Private Limited.
The legal entities of Valencelabs currently have 3 directors, including Munish Goyal, Minu Goyal, Harsh Dev Goyal.